# Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer

> **NCT00900133** · — · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 60 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** immunoenzyme technique
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00900133
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-04
- **Final completion:** 2006-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00900133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00900133, "Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00900133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*